Ticker
ACST

Price
3.40
Stock movement up
+- (%)
Company name
Acasti Pharma Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
25.28M
Ent value
19.12M
Price/Sales
1944.66
Price/Book
0.26
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
6.82%
1 year return
31.60%
3 year return
-50.10%
5 year return
-40.99%
10 year return
-40.34%
Last updated: 2024-04-08

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ACST does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1944.66
Price to Book0.26
EV to Sales1470.81

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count7.44M
EPS (TTM)-2.24
FCF per share (TTM)-1.81

Income statement

Loading...
Income statement data
Revenue (TTM)13.00K
Gross profit (TTM)0.00
Operating income (TTM)-18.16M
Net income (TTM)-16.63M
EPS (TTM)-2.24
EPS (1y forward)-2.94

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-139684.62%
Profit margin (TTM)-127892.31%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash26.24M
Net receivables778.00K
Total current assets33.43M
Goodwill12.96M
Intangible assets69.81M
Property, plant and equipment0.00
Total assets116.80M
Accounts payable3.36M
Short/Current long term debt503.00K
Total current liabilities3.43M
Total liabilities20.08M
Shareholder's equity96.72M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-13.45M
Capital expenditures (TTM)16.00K
Free cash flow (TTM)-13.46M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-17.19%
Return on Assets-14.23%
Return on Invested Capital-17.18%
Cash Return on Invested Capital-13.91%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.40
Daily high3.43
Daily low3.32
Daily Volume9K
All-time high1953.60
1y analyst estimate13.50
Beta1.22
EPS (TTM)-2.24
Dividend per share-
Ex-div date-
Next earnings date21 Jun 2024

Downside potential

Loading...
Downside potential data
ACSTS&P500
Current price drop from All-time high-99.83%-0.85%
Highest price drop-99.91%-56.47%
Date of highest drop22 Sep 20239 Mar 2009
Avg drop from high-86.44%-11.35%
Avg time to new high83 days13 days
Max time to new high2677 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ACST (Acasti Pharma Inc) company logo
Marketcap
25.28M
Marketcap category
Small-cap
Description
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Employees
0
Investor relations
-
SEC filings
CEO
Janelle D'Alvise
Country
USA
City
Laval
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...